SPY329.56+2.90 0.89%
DIA266.29+0.81 0.31%
IXIC11,162.96+158.10 1.44%

Morgan Stanley Maintains Equal-Weight on Editas Medicine, Lowers Price Target to $31

Morgan Stanley maintains Editas Medicine (NASDAQ:EDIT) with a Equal-Weight and lowers the price target from $32 to $31.

· 10/13/2020 08:50
Morgan Stanley maintains Editas Medicine (NASDAQ:EDIT) with a Equal-Weight and lowers the price target from $32 to $31.